Phoenix subcommittee backs $130,000 bioscience marketing push, highlights Mindcrowd study

The City of Phoenix Economic Development & the Arts Subcommittee on Sept. 10 recommended that the City Council approve up to $130,000 to continue the city's Bioscience Healthcare Strategic Initiative, including membership in the Arizona BioIndustry Association (AZ Bio) and a city pavilion at the 2026 BIO International convention.

The request, presented by Nathan Wright, deputy community economic director, and Claudia Whitehead, program manager for the initiative, came during the subcommittee's regular meeting and drew support from multiple council members.

“The city of Phoenix's bioscience healthcare strategic initiative ... would include research and development, entrepreneurs, precision medicine, health-care delivery, education and branding for the city,” Whitehead said as she summarized the program and results from the past year. Wright told the subcommittee the administration sought the subcommittee's recommendation to send the $130,000 request to the full City Council.

Nut graf: The initiative is intended to market Phoenix as a national bioscience hub and to support local company recruitment and partnerships. Presenters pointed to recent capital investment, new facilities and jobs in the life-sciences cluster as evidence that continued trade-show participation and industry engagement produce partnership and business leads.

By the numbers cited to the subcommittee: Phoenix-area bioscience projects have drawn more than $6.7 billion in new capital investment since 2019, added roughly 8 million square feet of primary facilities and created about 14,000 new jobs. Presenters said 80% of Arizona's clinical trials occur in Phoenix. At the BIO International Trade Show in Boston, the city hosted a delegation of more than 60, held about 400 meetings and identified roughly 180 potential opportunities; about 60% of the “hot prospects” were international, according to Whitehead.

Whitehead also described promotional results from the trade show and related campaigns: more than 1 million impressions from combined outreach and an estimated 1.8 million email, web and onsite sponsorship impressions tied to the BIO show presence. She highlighted local companies that drew attention at the conference, including Wexford Science & Technology's preleasing announcement for a new building and an early-stage canine cancer diagnostic from a company identified in the presentation as Calvary.

Council members asked about a research project featured in the presentation called Mindcrowd, an Internet‑based cognitive study tied to Phoenix-area researchers. “Our overall goal with Mindcrowd is to reach a million participants, and we're almost there,” Whitehead said, and the presenters told the subcommittee the study had more than 800,000 participants with more than 100,000 joining since the project was highlighted at the BIO trade show.

Councilwoman Pastor asked whether Mindcrowd's methods could be extended to study younger brains and neurodivergence. “I was thinking of young youth…if somebody would pick it up, to look at the brain of those young kids,” Pastor said. Whitehead and others responded that the city’s role is to support ecosystem partners and associations that advance research and that such studies are part of the broader research agenda.

The subcommittee voted to forward the request to the full City Council, with the meeting record stating the action “passes unanimously.” The presenters and council members characterized the initiative as a continuing marketing and business‑attraction effort rather than an operational funding stream for specific company projects.

Ending: The subcommittee's recommendation sends the $130,000 budget request and AZ Bio membership proposal to the City Council for final approval. If approved, the city plans to use the funds for a 2026 BIO International presence and associated AZ Bio engagement to pursue partnership leads and promote the Phoenix bioscience cluster.